Posts by tag: drug-development

Computational Neoantigen Prediction: Unlocking Personalized Immunotherapy

5 June 2025 @ 09:20

Blog: Computational Neoantigen Prediction: Unlocking Personalized Immunotherapy

How somatic variants are computationally translated into candidate neoantigens

Read more
Characterizing a Cancer Immunotherapy Target with Genomic Data

12 September 2024 @ 15:27

Case: Characterizing a Cancer Immunotherapy Target with Genomic Data

Dr. Melissa Vrohlings, Translational Science Leader of CDR-Life, shares her experiences with our Virtual Bioinformatics Core service

Read more
Investigating the Mechanism of Action of a Disease-Modifying Treatment for Parkinson’s Disease Using Bulk and Spatial Transcriptomics

29 April 2024 @ 15:24

Case: Investigating the Mechanism of Action of a Disease-Modifying Treatment for Parkinson’s Disease Using Bulk and Spatial Transcriptomics

Dr. Henri Huttunen from Herantis Pharma shares his experiences with our Virtual Bioinformatics Core service

Read more
Discovering targets and biomarkers for immunotherapies

17 September 2023 @ 14:20

Blog: Discovering targets and biomarkers for immunotherapies

Learn how tumor DNA- and RNA-sequencing enables the discovery of target antigens and response markers for immunotherapies

Read more
Tailored bioinformatics support for a clinical trial

3 March 2023 @ 12:50

Case: Tailored bioinformatics support for a clinical trial

Learn how Amazentis leveraged omics analyses in a clinical trial for a postbiotic

Read more
Identifying pharmacogenomic vulnerabilities in malaria treatment

14 October 2021 @ 09:26

Case: Identifying pharmacogenomic vulnerabilities in malaria treatment

Learn how Genevia Technologies helped to accelerate Karolinska Institute's malaria research.

Read more
Uncovering a drug’s mode of action with Genevia Technologies

2 March 2021 @ 19:50

Case: Uncovering a drug’s mode of action with Genevia Technologies

Learn how Genevia Technologies helped MiNa TX with mechanism of action analysis.

Read more
  • Contact
    • Send message
    • Book a meeting
    • Subscribe to newsletter
  • Analyses
    • DNA-seq data analysis
    • RNA-seq data analysis
    • Single-cell RNA-seq data analysis
    • Spatial transcriptomic data analysis
    • Epigenomic data analysis
    • Proteomic and metabolomic data analysis
  • References
    • Collaborations
    • Scientific references
    • Case studies
    • Bioinformatics buyer's guide
  • About us
    • Our team
    • Story & management
  • Careers
  • News
  • Blog
  • FAQ
  • Genevia Germany
  • Genevia Sweden
  • Genevia Finland
  • Cookie Declaration
 logo

Hämeenkatu 14 C 33
33100 Tampere, Finland

Telephone (office): +358 40 747 7672
Telephone (sales): +358 45 7870 1922
E-mail:

© 2014–2024 Genevia Technologies Oy
Webdesign: Nokikana / Webmaster: Blowback

 logo
  • Home
  • Service
  • Analyses
    • DNA-seq data analysis
    • RNA-seq data analysis
    • Single-cell RNA-seq data analysis
    • Spatial transcriptomic data analysis
    • Epigenomic data analysis
    • Proteomic and metabolomic data analysis
  • Research areas
    • Cancer
    • Genetics
    • Nervous system
    • Immunology
    • Immuno-oncology
    • Drug development
    • AI-driven drug discovery
    • Metabolism and endocrinology
    • Microbiology
  • References
    • Collaborations
    • Scientific references
    • Case studies
    • Bioinformatics buyer's guide
  • About us
    • Our team
    • Story & management
  • Careers
  • Blog
  • News
  • FAQ
  • Contact
    • Send message
    • Book a meeting
    • Subscribe to newsletter
  • Home
  • Service
  • Analyses
  • Research areas
  • References
  • About us
  • Careers
  • Blog
  • News
  • FAQ
  • Contact